Next Quarterly Earnings
Wednesday, July 22, 2026
CW 30
After-Hours
In 17 days
Medpace Holding is a leading global Contract Research Organization (CRO) providing comprehensive clinical development services. The company supports biopharmaceutical and medical device companies in drug development, from clinical trials to regulatory approval. With scientific expertise, Medpace drives innovation within the pharmaceutical and biotechnology industries.